Academic Molecular Pathologist
Apply NowCompany: Harvard Medical Faculty Physicians
Location: Boston, MA 02115
Description:
Academic Molecular Pathologist
Focus: With Additional Subspecialty Expertise in an Area of Anatomic Pathology or Clinical Pathology Desirable
(Academic Clinician or Physician-Scientist)
Department of Pathology
Harvard Medical Faculty Physicians at Beth Israel Deaconess Medical Center, Inc.
Harvard Medical School, Boston
The Department of Pathology at Beth Israel Deaconess Medical Center (BIDMC) is recruiting a full-time academic Molecular Pathologist. BIDMC is a tertiary care facility with 743 licensed beds and an internationally renowned principal teaching hospital of Harvard Medical School with NCI Comprehensive Cancer Center-affiliated Cancer Center.
The BIDMC Department of Pathology has launched new strategic initiatives in cutting-edge Precision Diagnostics (including cancer genomics, multiplex biomarker theranostics, and computational/digital pathology). In addition, the department will be engaged in the newly announced and exciting clinical partnership between Dana-Farber Cancer Institute (DFCI), BIDMC, and Harvard Medical Faculty Physicians (HMFP) to establish New England's only free-standing adult inpatient cancer hospital. The collaboration will bring together world-class clinicians to deliver transformational precision medicine in an environment solely dedicated to defeating cancer.
We are looking for an active, energetic, team-oriented faculty member to help us shape our future agenda and engage in areas that are being actively developed.
Strong diagnostic expertise in building and signing out molecular diagnostics (including genomic and transcriptomic NGS, methylation testing, liquid biopsy testing, long read sequencing) is required. Expertise or interest in developing cutting-edge "post-genomic" precision diagnostics such as Artificial Intelligence Pathology, multiomic diagnostics, or cancer proteomics and metabolomics are desirable. Strong interest in further developing the crucial role of Pathology in clinical trials is a plus, including new companion diagnostics.
Additionally, interest and expertise to sign out cases in an area of subspecialized Anatomic Pathology or Clinical Pathology is desirable.
Candidates with a strong clinical, translational, or laboratory-based research program are particularly encouraged to apply. Candidates with existing NIH grant funding will be supported by attractive research space and start-up funds to expand their programs.
The successful candidate will join a team of faculty, residents, and fellows to provide world-class diagnostics at BIDMC. Additionally, the candidate will support the vibrant training programs, including pathology residency program, and multiple pathology fellowship programs.
Applicants must be board certified in Pathology (AP, CP, or AP/CP) and Molecular Genetic Pathology.
The candidate will be appointed to the full-time faculty of Harvard Medical School at an academic rank commensurate with experience.
Research
Beth Israel Deaconess Medical Center consistently ranks as a national leader among independent hospitals in National Institutes of Health funding. Research funding totals over $229.8 million annually. BIDMC researchers run more than 850 active sponsored projects and 500 funded and non-funded clinical trials.
The Harvard-Thorndike Laboratory, the nation's oldest clinical research laboratory, has been located on this site since 1973. BIDMC also shares important clinical and research programs with institutions such as the Dana-Farber/Harvard Cancer Center, Joslin Diabetes Center, and Children's Hospital.
Who We Are
BIDMC is part of Beth Israel Lahey Health, a health care system that brings together academic medical centers and teaching hospitals, community and specialty hospitals, and more than 38,000 employees in a shared mission to expand access to great care and advance the science and practice of medicine through groundbreaking research and education.
Harvard Medical Faculty Physicians at Beth Israel Deaconess Medical Center (HMFP) is one of the largest physician organizations in New England, dedicated to excellence and innovation in patient care, education, and research. As a physician-led organization, HMFP partners with more than 2,200 providers to support the delivery of exceptional care, promote professional development and diversity, and foster balance at work and home. HMFP physicians have faculty affiliations with Harvard Medical School (HMS) and provide care throughout the Beth Israel Lahey Health (BILH) system and additional hospitals across Massachusetts.
For further questions or confidential position inquiries, please contact Dr. Gyorgy Abel, Director of Molecular Pathology and Genomics at BIDMC: gyorgy_abel@hms.harvard.edu
Please apply online at www.hmfphysicians.org/careers.
Focus: With Additional Subspecialty Expertise in an Area of Anatomic Pathology or Clinical Pathology Desirable
(Academic Clinician or Physician-Scientist)
Department of Pathology
Harvard Medical Faculty Physicians at Beth Israel Deaconess Medical Center, Inc.
Harvard Medical School, Boston
The Department of Pathology at Beth Israel Deaconess Medical Center (BIDMC) is recruiting a full-time academic Molecular Pathologist. BIDMC is a tertiary care facility with 743 licensed beds and an internationally renowned principal teaching hospital of Harvard Medical School with NCI Comprehensive Cancer Center-affiliated Cancer Center.
The BIDMC Department of Pathology has launched new strategic initiatives in cutting-edge Precision Diagnostics (including cancer genomics, multiplex biomarker theranostics, and computational/digital pathology). In addition, the department will be engaged in the newly announced and exciting clinical partnership between Dana-Farber Cancer Institute (DFCI), BIDMC, and Harvard Medical Faculty Physicians (HMFP) to establish New England's only free-standing adult inpatient cancer hospital. The collaboration will bring together world-class clinicians to deliver transformational precision medicine in an environment solely dedicated to defeating cancer.
We are looking for an active, energetic, team-oriented faculty member to help us shape our future agenda and engage in areas that are being actively developed.
Strong diagnostic expertise in building and signing out molecular diagnostics (including genomic and transcriptomic NGS, methylation testing, liquid biopsy testing, long read sequencing) is required. Expertise or interest in developing cutting-edge "post-genomic" precision diagnostics such as Artificial Intelligence Pathology, multiomic diagnostics, or cancer proteomics and metabolomics are desirable. Strong interest in further developing the crucial role of Pathology in clinical trials is a plus, including new companion diagnostics.
Additionally, interest and expertise to sign out cases in an area of subspecialized Anatomic Pathology or Clinical Pathology is desirable.
Candidates with a strong clinical, translational, or laboratory-based research program are particularly encouraged to apply. Candidates with existing NIH grant funding will be supported by attractive research space and start-up funds to expand their programs.
The successful candidate will join a team of faculty, residents, and fellows to provide world-class diagnostics at BIDMC. Additionally, the candidate will support the vibrant training programs, including pathology residency program, and multiple pathology fellowship programs.
Applicants must be board certified in Pathology (AP, CP, or AP/CP) and Molecular Genetic Pathology.
The candidate will be appointed to the full-time faculty of Harvard Medical School at an academic rank commensurate with experience.
Research
Beth Israel Deaconess Medical Center consistently ranks as a national leader among independent hospitals in National Institutes of Health funding. Research funding totals over $229.8 million annually. BIDMC researchers run more than 850 active sponsored projects and 500 funded and non-funded clinical trials.
The Harvard-Thorndike Laboratory, the nation's oldest clinical research laboratory, has been located on this site since 1973. BIDMC also shares important clinical and research programs with institutions such as the Dana-Farber/Harvard Cancer Center, Joslin Diabetes Center, and Children's Hospital.
Who We Are
BIDMC is part of Beth Israel Lahey Health, a health care system that brings together academic medical centers and teaching hospitals, community and specialty hospitals, and more than 38,000 employees in a shared mission to expand access to great care and advance the science and practice of medicine through groundbreaking research and education.
Harvard Medical Faculty Physicians at Beth Israel Deaconess Medical Center (HMFP) is one of the largest physician organizations in New England, dedicated to excellence and innovation in patient care, education, and research. As a physician-led organization, HMFP partners with more than 2,200 providers to support the delivery of exceptional care, promote professional development and diversity, and foster balance at work and home. HMFP physicians have faculty affiliations with Harvard Medical School (HMS) and provide care throughout the Beth Israel Lahey Health (BILH) system and additional hospitals across Massachusetts.
For further questions or confidential position inquiries, please contact Dr. Gyorgy Abel, Director of Molecular Pathology and Genomics at BIDMC: gyorgy_abel@hms.harvard.edu
Please apply online at www.hmfphysicians.org/careers.